When should a technetium‑99m DTPA renal scan be ordered and what is the proper protocol for performing it?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

DTPA Renal Scan: Indications and Protocol

When to Order

Tc-99m DTPA renal scans should be ordered for evaluating severe grade 3 and 4 hydronephrosis in infants (delayed until at least 2 months of age due to low neonatal glomerular filtration rate), but Tc-99m MAG3 is strongly preferred over DTPA when obstruction or impaired renal function is suspected. 1

Primary Indications

In pediatric hydronephrosis:

  • Severe grade 3 or 4 hydronephrosis evaluation, typically performed in concert with VCUG 1
  • Assessment of split renal function and renal washout curves 1
  • Critical timing consideration: Examinations must be delayed until at least 2 months of age due to lower glomerular filtration rate in newborns 1

In adult patients:

  • Renal visualization and assessment of renal perfusion 2
  • Estimation of glomerular filtration rate 2
  • Brain imaging (intravenous administration) 2
  • Renal transplant dysfunction evaluation (though not routinely recommended as baseline per European Association of Urology guidelines) 3

Important Limitation

DTPA has significant disadvantages compared to MAG3: Its extraction fraction is only approximately 20%, resulting in greater background activity versus renal activity, making it inferior for evaluating obstruction or impaired renal function 1. DTPA is excreted primarily by glomerular filtration and is not excreted by tubules, limiting its utility in obstruction evaluation 3.

Proper Protocol

Dosing for Renal Scintigraphy

Adults:

  • Renal visualization and perfusion assessment: 370-740 MBq (10-20 mCi) intravenous 2
  • Renal visualization with GFR estimation: 111-185 MBq (3-5 mCi) intravenous 2
  • GFR estimation only (no imaging): 7.4-18.5 MBq (0.2-0.5 mCi) intravenous 2

Pediatric patients:

  • Renal visualization and perfusion: 3.7-7.4 MBq/kg (0.1-0.2 mCi/kg) intravenous 2
  • Minimum dose: 37 MBq (1 mCi) 2
  • Maximum dose: 185 MBq (5 mCi) 2
  • GFR estimation only: 7.4-18.5 MBq (0.2-0.5 mCi) 2

Image Acquisition

For renal visualization and perfusion assessment:

  • Immediate dynamic imaging following injection 2
  • Static imaging 1-30 minutes after injection 2

For GFR estimation with imaging:

  • Immediate dynamic imaging 2
  • Static imaging 1-30 minutes after injection 2

For GFR estimation without imaging:

  • Blood sampling only is performed 2

Safety Considerations

  • Use waterproof gloves and effective shielding, including syringe shields, during preparation and handling 2
  • Do not administer more than one dose 2

Clinical Decision Algorithm

When evaluating pediatric hydronephrosis:

  1. If patient is <2 months old: Delay nuclear medicine imaging due to immature glomerular filtration 1

  2. If patient is ≥2 months old with severe (grade 3-4) hydronephrosis:

    • First choice: Order Tc-99m MAG3 (not DTPA) if obstruction or impaired function is suspected 1
    • DTPA acceptable only if: Normal renal function and no suspected obstruction 1
  3. Interpretation for surgical decision-making:

    • T1/2 >20 minutes on time-activity curve indicates obstruction 1
    • <40% differential renal function indicates need for intervention 1
    • 5% deterioration on consecutive scans indicates progressive dysfunction 1

For renal transplant evaluation:

  • DTPA can monitor perfusion (blood flow) and uptake (glomerular filtration rate) 3
  • DTPA perfusion patterns are more sensitive than MAG3 in diagnosing transplant dysfunction 3
  • However, routine baseline dynamic renal scintigraphy is not recommended per current EAU guidelines 3

Common Pitfalls

  • Using DTPA instead of MAG3 in obstruction: DTPA's primary glomerular filtration mechanism and lack of tubular excretion makes it inferior for obstruction evaluation, as it only demonstrates early impact on glomerular filtration 3
  • Imaging too early in neonates: The lower glomerular filtration rate in newborns necessitates waiting until at least 2 months of age 1
  • Misinterpreting background activity: DTPA's lower extraction fraction (20%) creates more background noise compared to MAG3 (40-50% extraction fraction), potentially obscuring renal detail 1

References

Guideline

acr appropriateness criteria® antenatal hydronephrosis-infant.

Journal of the American College of Radiology, 2020

Guideline

acr appropriateness criteria® renal transplant dysfunction: 2024 update.

Journal of the American College of Radiology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.